Unraveling the Mysteries of Brain Cancer from Diagnosis to Treatment

Dyandevi Mathure1, Sejal Bhandare1, Dipanjan Karati2

  • 1Department of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Poona College of Pharmacy, Pune, India.

PubMed

Insights

Nanoparticles offer a promising solution for brain cancer treatment by overcoming the limitations of conventional therapies. These advanced delivery systems enable targeted diagnosis and therapy, improving patient outcomes.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Brain cancer treatment faces challenges due to the blood-brain barrier and non-specific drug delivery.
  • Current therapies often exhibit limited efficacy and potential toxicity.
  • Multifunctional nanoplatforms offer a novel approach to overcome these limitations.

Purpose of the Study:

  • To review recent advancements in nanoparticle-based brain cancer treatment and detection.
  • To discuss the advantages of nanoparticle drug delivery systems.
  • To explore various nanoparticle systems and their applications in oncology.

Main Methods:

  • Literature review of current research on nanoparticles for brain cancer.
  • Analysis of nanoparticle characteristics and their role in overcoming biological barriers.
  • Discussion of integrated nanoplatforms for diagnosis and therapy.

Main Results:

  • Nanoparticles demonstrate potential for targeted drug delivery across the blood-brain barrier.
  • Multifunctional nanoplatforms enable simultaneous diagnosis, treatment, and monitoring.
  • Various nanoparticle systems show promise for enhancing brain cancer therapy.

Conclusions:

  • Nanoparticle-based strategies represent a significant advancement in brain cancer management.
  • These platforms offer improved specificity and efficacy compared to conventional treatments.
  • Further research into nanomedicine holds great potential for future brain cancer therapies.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
324
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K